Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Seizure ; 93: 44-50, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34687985

RESUMEN

PURPOSE: In patients diagnosed with epilepsy, decreased ratio of N-acetyl aspartate to creatine (NAA/Cr) measured in magnetic resonance spectroscopy (MRS) has been accepted as a sign of neuronal cell loss or dysfunction. In this study, we aimed to determine whether a similar neuronal cell loss is present in a group of encephalopathy with electrical status epilepticus in sleep (ESES) patients METHODS: We performed this case-control study at a tertiary pediatric neurology center with patients with ESES. Inclusion criteria for the patient group were as follows: 1) a spike-wave index of at least 50%, 2) acquired neuropsychological regression, 3) normal cranial MRI. Eventually, a total of 21 patients with ESES and 17 control subjects were enrolled in the study. MRI of all control subjects was also within normal limits. 3D Slicer program was used for the analysis of thalamic and brain volumes. LCModel spectral fitting software was used to analyze single-voxel MRS data from the right and left thalamus of the subjects. RESULTS: The mean age was 8.0 ± 1.88 years and 8.3 ± 1.70 years in ESES patients and the control subjects. After correcting for the main potential confounders (age and gender) with a linear regression model, NAA/Creatine ratio of the right thalamus was significantly lower in the ESES patient group compared to the healthy control group (p = 0.026). Likewise, the left thalamus NAA/Cr ratio was significantly lower in the ESES patient group than the healthy control group (p = 0.007). After correcting for age and gender, right thalamic volume was not statistically significantly smaller in ESES patients than in healthy controls (p = 0.337), but left thalamic volume was smaller in ESES patients than in healthy controls (p = 0.024). CONCLUSION: In ESES patients, the NAA/Creatine ratio, which is an indicator of neuronal cell loss or dysfunction in the right and left thalamus, which appears regular on MRI, was found to be significantly lower than the healthy control group. This metabolic-induced thalamic dysfunction, which was reported for the first time up to date, may play a role in ESES epileptogenesis.


Asunto(s)
Estado Epiléptico , Estudios de Casos y Controles , Niño , Humanos , Imagen por Resonancia Magnética , Sueño , Estado Epiléptico/diagnóstico por imagen , Estado Epiléptico/etiología , Tálamo/diagnóstico por imagen
2.
Med Biol Eng Comput ; 55(8): 1303-1315, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27826817

RESUMEN

The purpose of this study was to apply compressed sensing method for accelerated phosphorus MR spectroscopic imaging (31P-MRSI) of human brain in vivo at 3T. Fast 31P-MRSI data of five volunteers were acquired on a 3T clinical MR scanner using pulse-acquire sequence with a pseudorandom undersampling pattern for a data reduction factor of 5.33 and were reconstructed using compressed sensing. Additionally, simulated 31P-MRSI human brain tumor datasets were created to analyze the effects of k-space sampling pattern, data matrix size, regularization parameters of the reconstruction, and noise on the compressed sensing accelerated 31P-MRSI data. The 31P metabolite peak ratios of the full and compressed sensing accelerated datasets of healthy volunteers in vivo were similar according to the results of a Bland-Altman test. The estimated effective spatial resolution increased with reduction factor and sampling more at the k-space center. A lower regularization parameter for both total variation and L1-norm penalties resulted in a better compressed sensing reconstruction of 31P-MRSI. Although the root-mean-square error increased with noise levels, the compressed sensing reconstruction was robust for up to a reduction factor of 10 for the simulated data that had sharply defined tumor borders. As a result, compressed sensing was successfully applied to accelerate 31P-MRSI of human brain in vivo at 3T.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias Encefálicas/metabolismo , Compresión de Datos/métodos , Espectroscopía de Resonancia Magnética/métodos , Imagen Molecular/métodos , Compuestos de Fósforo/metabolismo , Fósforo/farmacocinética , Femenino , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Procesamiento de Señales Asistido por Computador
3.
Artículo en Inglés | MEDLINE | ID: mdl-25570471

RESUMEN

This study aims classification of phosphorus magnetic resonance spectroscopic imaging ((31)P-MRSI) data of human brain tumors using machine-learning algorithms. The metabolite peak intensities and ratios were estimated for brain tumor and healthy (31)P MR spectra acquired at 3T. The spectra were classified based on metabolite characteristics using logistic regression and support vector machine. This study showed that machine learning could be successfully applied for classification of (31)P-MR spectra of brain tumors. Future studies will measure the performance of classification algorithms for (31)P-MRSI of brain tumors in a larger patient cohort.


Asunto(s)
Neoplasias Encefálicas/diagnóstico , Imagen por Resonancia Magnética/métodos , Espectroscopía de Resonancia Magnética/métodos , Fósforo , Máquina de Vectores de Soporte , Adulto , Femenino , Humanos , Modelos Logísticos , Persona de Mediana Edad , Curva ROC
4.
Artículo en Inglés | MEDLINE | ID: mdl-23366089

RESUMEN

This study aims at assessing the performance of compressed sensing method for faster phosphorus magnetic resonance spectroscopic imaging ((31)P-MRSI) of human brain. A simulated 2D (31)P-MRSI dataset containing a tumor region and a healthy region was created based on the metabolite peak intensities and ratios of a volunteer dataset acquired at 3T. k-space data was randomly undersampled, and reconstructed using compressed sensing algorithm. This simulation study showed that compressed sensing reconstruction could be applied for faster (31)P-MRSI. Future studies will measure the performance of compressed sensing reconstruction for (31)P-MRSI in volunteers and patients with brain tumors.


Asunto(s)
Algoritmos , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patología , Espectroscopía de Resonancia Magnética/métodos , Modelos Biológicos , Fósforo/metabolismo , Diagnóstico por Imagen/métodos , Humanos , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA